Search research articles
Contact Us
Filters
Showing results (91-100 of 167) with videos related to
Page
of 17
Sort By:
Frontiers in Oncology
|
January 26, 2024
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy
Silvia Mihaela Ilie, Nathalie Briot, Guillaume Constatin, et al.
Breast Cancer Research : BCR
|
November 19, 2022
Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers
Elise Ballot, Loïck Galland, Hugo Mananet, et al.
British Journal of Cancer
|
January 21, 2021
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial
Luc Cabel, Frédérique Berger, Paul Cottu, et al.
Annals of Surgical Oncology
|
January 15, 2014
Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection
Francois Ghiringhelli, Damien Bichard, Samuel Limat, et al.
Cancer Research
|
August 7, 2016
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen
Emeric Limagne, Romain Euvrard, Marion Thibaudin, et al.
Autophagy
|
June 1, 2012
Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens
Sylvain Ladoire, Kariman Chaba, Isabelle Martins, et al.
European Urology Oncology
|
June 1, 2024
Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review
Michael Baboudjian, Arthur Peyrottes, Charles Dariane, et al.
Bulletin Du Cancer
|
November 28, 2021
Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort
Hélène Costaz, Delphine Boulle, Aurélie Bertaut, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 23, 2021
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations
Anthony Bergeron, Gaëtan MacGrogan, Aurélie Bertaut, et al.
Cancer Chemotherapy and Pharmacology
|
January 8, 2022
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach
Manon Reda, Pauline Macaire, Hélène Bellio, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 167) with videos related to
Sort By:
Page
of 17
Frontiers in Oncology
|
January 26, 2024
Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy
Silvia Mihaela Ilie, Nathalie Briot, Guillaume Constatin, et al.
Breast Cancer Research : BCR
|
November 19, 2022
Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers
Elise Ballot, Loïck Galland, Hugo Mananet, et al.
British Journal of Cancer
|
January 21, 2021
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial
Luc Cabel, Frédérique Berger, Paul Cottu, et al.
Annals of Surgical Oncology
|
January 15, 2014
Bevacizumab efficacy in metastatic colorectal cancer is dependent on primary tumor resection
Francois Ghiringhelli, Damien Bichard, Samuel Limat, et al.
Cancer Research
|
August 7, 2016
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen
Emeric Limagne, Romain Euvrard, Marion Thibaudin, et al.
Autophagy
|
June 1, 2012
Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens
Sylvain Ladoire, Kariman Chaba, Isabelle Martins, et al.
European Urology Oncology
|
June 1, 2024
Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review
Michael Baboudjian, Arthur Peyrottes, Charles Dariane, et al.
Bulletin Du Cancer
|
November 28, 2021
Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort
Hélène Costaz, Delphine Boulle, Aurélie Bertaut, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 23, 2021
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations
Anthony Bergeron, Gaëtan MacGrogan, Aurélie Bertaut, et al.
Cancer Chemotherapy and Pharmacology
|
January 8, 2022
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach
Manon Reda, Pauline Macaire, Hélène Bellio, et al.
Page
of 17